{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T05:35:44Z","timestamp":1771047344623,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T00:00:00Z","timestamp":1665532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T00:00:00Z","timestamp":1665532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100023331","name":"LEO Pharma","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100023331","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s13555-022-00824-9","type":"journal-article","created":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T08:03:03Z","timestamp":1665561783000},"page":"2589-2600","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Matching-Adjusted Indirect Comparison of Long-Term Efficacy and Safety Outcomes for Calcipotriol Plus Betamethasone Dipropionate Foam Versus Halobetasol Proprionate Plus Tazarotene Lotion in the Treatment of Plaque Psoriasis"],"prefix":"10.1007","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1932-258X","authenticated-orcid":false,"given":"David N.","family":"Adam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie Y.","family":"Jablonski Bernasconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Thoning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jashin J.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,12]]},"reference":[{"key":"824_CR1","doi-asserted-by":"publisher","first-page":"ii18","DOI":"10.1136\/ard.2004.033217","volume":"64","author":"RGB Langley","year":"2005","unstructured":"Langley RGB, Krueger GG, Griffiths CEM. Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis. 2005;64:ii18\u201323.","journal-title":"Ann Rheum Dis"},{"key":"824_CR2","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.jaad.2008.02.039","volume":"58","author":"A Menter","year":"2008","unstructured":"Menter A, Gottlieb A, Feldman SR, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol. 2008;58:826\u201350.","journal-title":"J Am Acad Dermatol"},{"key":"824_CR3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2340\/00015555-0764","volume":"90","author":"TM Ljosaa","year":"2010","unstructured":"Ljosaa TM, Rustoen T, M\u00f6rk C, et al. Skin pain and discomfort in psoriasis: an exploratory study of symptom prevalence and characteristics. Acta Derm Venereol. 2010;90:39\u201345.","journal-title":"Acta Derm Venereol"},{"key":"824_CR4","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jaad.2009.07.003","volume":"63","author":"S Gowda","year":"2010","unstructured":"Gowda S, Goldblum OM, McCall WV, Feldman SR. Factors affecting sleep quality in patients with psoriasis. J Am Acad Dermatol. 2010;63:114\u201323.","journal-title":"J Am Acad Dermatol"},{"issue":"871\u201381","key":"824_CR5","first-page":"e1","volume":"70","author":"MG Lebwohl","year":"2014","unstructured":"Lebwohl MG, Bachelez H, Barker J, et al. Patient perspectives in the management of psoriasis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey. J Am Acad Dermatol. 2014;70(871\u201381):e1-30.","journal-title":"J Am Acad Dermatol"},{"key":"824_CR6","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2310\/7750.2009.08071","volume":"13","author":"CW Lynde","year":"2009","unstructured":"Lynde CW, Poulin Y, Guenther L, Jackson C. The burden of psoriasis in Canada: insights from the pSoriasis Knowledge IN Canada (SKIN) survey. J Cutan Med Surg. 2009;13:235\u201352.","journal-title":"J Cutan Med Surg"},{"key":"824_CR7","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1111\/j.1365-2230.2012.04457.x","volume":"37","author":"A Anstey","year":"2012","unstructured":"Anstey A, McAteer H, Kamath N, Percival F. Extending psychosocial assessment of patients with psoriasis in the UK, using a self-rated, web-based survey. Clin Exp Dermatol. 2012;37:735\u201340.","journal-title":"Clin Exp Dermatol"},{"key":"824_CR8","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.jaad.2020.07.087","volume":"84","author":"CA Elmets","year":"2021","unstructured":"Elmets CA, Korman NJ, Prater EF, et al. Joint AAD-NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures. J Am Acad Dermatol. 2021;84:432\u201370.","journal-title":"J Am Acad Dermatol"},{"key":"824_CR9","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3109\/09546634.2015.1083935","volume":"27","author":"J Koo","year":"2016","unstructured":"Koo J, Tyring S, Werschler WP, et al. Superior efficacy of calcipotriene and betamethasone dipropionate aerosol foam versus ointment in patients with psoriasis vulgaris\u2014a randomized phase II study. J Dermatol Treat. 2016;27:120\u20137.","journal-title":"J Dermatol Treat"},{"key":"824_CR10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/jdv.13859","volume":"31","author":"C Paul","year":"2017","unstructured":"Paul C, Stein Gold L, Cambazard F, et al. Calcipotriol plus betamethasone dipropionate aerosol foam provides superior efficacy vs gel in patients with psoriasis vulgaris: randomized, controlled PSO-ABLE study. J Eur Acad Dermatol Venereol. 2017;31:119\u201326.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"824_CR11","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1111\/jdv.17113","volume":"35","author":"MG Lebwohl","year":"2021","unstructured":"Lebwohl MG, Stein Gold L, Papp K, et al. Long-term safety and efficacy of a fixed-combination halobetasol propionate 0.01%\/tazarotene 0.045% lotion in moderate-to-severe plaque psoriasis: phase 3 open-label study. J Eur Acad Dermatol Venereol. 2021;35:1152\u201360.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"824_CR12","first-page":"855","volume":"17","author":"JL Sugarman","year":"2018","unstructured":"Sugarman JL, Weiss J, Tanghetti EA, et al. Safety and efficacy of a fixed combination halobetasol and tazarotene lotion in the treatment of moderate-to-severe plaque psoriasis: a pooled analysis of two phase 3 studies. J Drugs Dermatol. 2018;17:855\u201361.","journal-title":"J Drugs Dermatol"},{"key":"824_CR13","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jaad.2018.03.040","volume":"79","author":"LS Gold","year":"2018","unstructured":"Gold LS, Lebwohl MG, Sugarman JL, et al. Safety and efficacy of a fixed combination of halobetasol and tazarotene in the treatment of moderate-to-severe plaque psoriasis: results of 2 phase 3 randomized controlled trials. J Am Acad Dermatol. 2018;79:287\u201393.","journal-title":"J Am Acad Dermatol"},{"key":"824_CR14","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1177\/0272989X17725740","volume":"38","author":"DM Phillippo","year":"2018","unstructured":"Phillippo DM, Ades AE, Dias S, Palmer S, Abrams KR, Welton NJ. Methods for population-adjusted indirect comparisons in health technology appraisal. Med Decis Making. 2018;38:200\u201311.","journal-title":"Med Decis Making"},{"key":"824_CR15","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.jval.2012.05.004","volume":"15","author":"JE Signorovitch","year":"2012","unstructured":"Signorovitch JE, Sikirica V, Erder MH, et al. Matching-adjusted indirect comparisons: a new tool for timely comparative effectiveness research. Value Health. 2012;15:940\u20137.","journal-title":"Value Health"},{"key":"824_CR16","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1080\/13696998.2020.1722139","volume":"23","author":"JJ Wu","year":"2020","unstructured":"Wu JJ, Hansen JB, Patel DS, Nyholm N, Veverka KA, Swensen AR. Effectiveness comparison and incremental cost-per-responder analysis of calcipotriene 0.005%\/betamethasone dipropionate 0.064% foam vs halobetasol 0.01%\/tazarotene 0.045% lotion for plaque psoriasis: a matching-adjusted indirect comparative analysis. J Med Econ. 2020;23:641\u20139.","journal-title":"J Med Econ"},{"key":"824_CR17","doi-asserted-by":"publisher","first-page":"935","DOI":"10.2165\/11538370-000000000-00000","volume":"28","author":"JE Signorovitch","year":"2010","unstructured":"Signorovitch JE, Wu EQ, Yu AP, et al. Comparative effectiveness without head-to-head trials: a method for matching-adjusted indirect comparisons applied to psoriasis treatment with adalimumab or etanercept. Pharmacoeconomics. 2010;28:935\u201345.","journal-title":"Pharmacoeconomics"},{"key":"824_CR18","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.jaad.2020.09.037","volume":"84","author":"M Lebwohl","year":"2021","unstructured":"Lebwohl M, Kircik L, Lacour JP, et al. Twice-weekly topical calcipotriene\/betamethasone dipropionate foam as proactive management of plaque psoriasis increases time in remission and is well tolerated over 52 weeks (PSO-LONG trial). J Am Acad Dermatol. 2021;84:1269\u201377.","journal-title":"J Am Acad Dermatol"},{"key":"824_CR19","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1111\/jdv.15369","volume":"33","author":"AP Bewley","year":"2019","unstructured":"Bewley AP, Shear NH, Calzavara-Pinton PG, Hansen JB, Nyeland ME, Signorovitch J. Calcipotriol plus betamethasone dipropionate aerosol foam vs apremilast, methotrexate, acitretin or fumaric acid esters for the treatment of plaque psoriasis: a matching-adjusted indirect comparison. J Eur Acad Dermatol Venereol. 2019;33:1107\u201315.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"824_CR20","first-page":"123","volume":"11","author":"P Hampton","year":"2021","unstructured":"Hampton P, Borg E, Hansen JB, Augustin M. Efficacy of brodalumab and guselkumab in patients with moderate-to-severe plaque psoriasis who are inadequate responders to ustekinumab: a matching adjusted indirect comparison. Psoriasis (Auckl). 2021;11:123\u201331.","journal-title":"Psoriasis (Auckl)"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-022-00824-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-022-00824-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-022-00824-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T09:40:12Z","timestamp":1666431612000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-022-00824-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,12]]},"references-count":20,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["824"],"URL":"https:\/\/doi.org\/10.1007\/s13555-022-00824-9","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,12]]},"assertion":[{"value":"2 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}